A specific assay has been developed for a blood-borne non-A, non-B hepatitis (NANBH) virus in which a polypeptide synthesized in recombinant yeast clones of the hepatitis C virus (HCV) is used to capture circulating viral antibodies. HCV antibodies were detected in six of seven human sera that were shown previously to transmit NANBH to chimpanzees. Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses. About 80 percent of chronic, post-transfusion NANBH (PT-NANBH) patients from Italy and Japan had circulating HCV antibody; a much lower frequency (15 percent) was observed in acute, resolving infections. In addition, 58 percent of NANBH patients from the United States with no identifiable source of parenteral exposure to the virus were also positive for HCV antibody. These data indicate that HCV is a major cause of NANBH throughout the world.

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.2496467DOI Listing

Publication Analysis

Top Keywords

non-a non-b
8
non-b hepatitis
8
united states
8
hcv antibody
8
nanbh
6
hcv
5
assay circulating
4
circulating antibodies
4
antibodies major
4
major etiologic
4

Similar Publications

Total Percutaneous Transfemoral Endovascular Treatment of Non-A Non-B Aortic Dissection.

JACC Case Rep

January 2025

Chinese Institutes for Medical Research and Anzhen Hospital, Capital Medical University, Beijing, China.

Although open repair remains the mainstream treatment for aortic arch dissection, its surgical complexity and perioperative complications are significant. We developed a novel stentgraft system for less-invasive endovascular aortic arch repair. We successfully performed a total percutaneous transfemoral endovascular repair of aortic arch dissection using a novel off-the-shelf endograft system.

View Article and Find Full Text PDF

Non-A non-B aortic dissection is considered a rare nosological entity, included in the Stanford classification, representing a small percentage of the total aortic dissections that occur annually. Regarding this form, the literature reports a more complicated disease course compared to other types of dissection. We describe the case of a 76-year-old patient who accessed the triage section of an emergency department for a polytrauma picture and, after surgical treatment of a leg fracture, received a diagnosis of non-A non-B aortic dissection, "localized" to the arch and incidentally detected.

View Article and Find Full Text PDF

Objective: Acute aortic dissection remains a serious emergency in the field of cardiovascular medicine and a challenge for cardiothoracic surgeons. In the present study, we seek to compare the outcomes of different surgical techniques in the repair of type A acute aortic dissection.

Methods: Between April 2015 and May 2023, 213 patients (82 women, aged: 63.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to improve aortic arch replacement efficiency using a new frozen elephant trunk (FET) prosthesis designed for better connection to the left subclavian artery (LSA).
  • Four patients underwent surgery with this customized device, and all were discharged in good condition after the procedure.
  • While the initial results are promising, highlighting the potential of the new prosthesis, further clinical studies are needed to analyze its effectiveness and optimize design parameters.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!